English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no differences in relief of mild-to-moderate COVID-19 symptoms between participants taking ivermectin and participants taking a placebo.
Tag: Ivermectin
Judge Hears Case Filed by Renowned ICU Doctor: Do Doctors or Administrators Decide Treatment for Critically Ill COVID Patients?
Arguments over a complaint filed in the Circuit Court for the City of Norfolk, Virginia, were presented today to decide if patients of one of the world’s most published critical care physicians can be given lifesaving treatments for COVID-19 that a local hospital system has prohibited.
The jury is still out on the effectiveness of ivermectin in treating COVID-19, despite claims that it works or that it’s useless
Ivermectin is used to fight worms and other parasites in animals and humans. But some people are taking it to treat COVID-19, despite warnings from experts and poisonings tied to the drug.
Health Agencies Continue to Fail the Public, Causing People to File Suits for Access to Treatments to Save Loved Ones
The FLCCC Alliance to host program with special guests, including patients & their families who’ve fought legal battles to get access to life-saving treatments for COVID
Rutgers Toxicologist Available to Discuss Dangers of Taking Livestock Deworming Drug for COVID-19
Rutgers Professor Lewis Nelson is available to discuss the dangers of people taking the livestock deworming drug ivermectin to try to treat COVID-19. Demand for the drug is surging nationwide despite warnings from the Food and Drug Administration and the…
Joint Statement of the FLCCC Alliance and British Ivermectin Recommendation Development Group on Retraction of Early Research on Ivermectin
The Front Line COVID-19 Critical Care Alliance (FLCCC), a group of highly published, world-renowned critical care physicians and scholars, and the British Ivermectin Recommendation Development Group (BIRD), a U.K. based group of medical and scientific experts from over 15 countries, are concerned over the misrepresentation of science in the recent article published in the Guardian regarding the withdrawal of Professor Emeritus Ahmed Elgazzar’s study into ivermectin that was first posted December 16, 2020.
FLCCC Statement on the Irregular Actions of Public Health Agencies & the Disinformation Campaign Against Ivermectin
FLCCC Alliance calls for whistleblower to step forward from within WHO, the FDA, the NIH, Merck, or Unitaid to counter this misrepresentation
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
After COVID-19 emerged on U.S shores, providers began reviewing the emerging basic science, translational, and clinical data to identify potentially effective treatment options. In addition, a multitude of both novel and repurposed therapeutic agents were used empirically and studied within clinical trials.
Front Line COVID-19 Critical Care Alliance Statement on Weak Guidance on Ivermectin from the World Health Organization (WHO)
WHO ignores significant data, including several large clinical trials, while claiming insufficient evidence to recommend the use of ivermectin to prevent and treat COVID-19
More Medical and Scientific Authorities Around the World Recognize Ivermectin as a Safe and Effective Prevention and Treatment for COVID-19
Front Line COVID-19 Critical Care Alliance to Convene Global Panel of Leading Experts to Discuss the Latest Research on Preventing and Treating COVID-19 with Ivermectin
FLCCC Alliance issues open letter to UK researchers planning a new trial to test ivermectin for use in COVID-19
FLCCC Alliance’s response to the University of Oxford’s planned ivermectin Randomized Controlled Trial.
FLCCC Alliance issues public response to new NIH recommendation on the use of ivermectin
The Front Line COVID-19 Critical Care Alliance (FLCCC) has issued a public response to the National Institutes of Health (NIH) regarding the NIH COVID-19 Treatment Guidelines Panel’s “neither for nor against” recommendation for the use of ivermectin in the treatment of COVID-19.
NIH Revises Treatment Guidelines for Ivermectin for the Treatment of COVID-19
NIH Revises Treatment Guidelines for Ivermectin for the Treatment of COVID-19 Ivermectin is Now a Therapeutic Option for Doctors & Prescribers
Updated Dosing Strategy for the I-MASK+ Protocol
The Critical Care physicians of the Front Line COVID-19 Critical Care Alliance (FLCCC) have announced an immediate update to the dosing strategy of their I-Mask+ Protocol for the prevention and treatment of COVID-19.
Front Line COVID-19 Critical Care Alliance (FLCCC) Invited to the National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel to Present Latest Data on Ivermectin
FLCCC Urges Review of Current Data and an Updated NIH Guidance
Dr. Pierre Kory, president of the FLCCC Alliance testifies before Senate Committee on Homeland Security and Governmental Affairs looking into early outpatient COVID-19 treatment
“It will all be needless death from here on out, given that there is a readily available scientific solution to the pandemic,” Kory says.